Melinda C Power Selected Research

beta-hexachlorocyclohexane

10/2017

Persistent organic pollutants and mortality in the United States, NHANES 1999-2011.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melinda C Power Research Topics

Disease

15	Cognitive Dysfunction 06/2022 - 02/2014
8	Dementia (Dementias) 06/2022 - 04/2015
7	Atherosclerosis 06/2022 - 12/2017
5	Hypertension (High Blood Pressure) 01/2022 - 10/2014
3	Stroke (Strokes) 01/2021 - 01/2018
3	Inflammation (Inflammations) 01/2018 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2020
2	Lacunar Stroke 01/2021 - 01/2019
1	Respiratory Sounds (Crackle) 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Unconsciousness (Loss of Consciousness) 12/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021
1	Albuminuria 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2019
1	Heart Failure 01/2019
1	Hyperglycemia 01/2019
1	Hearing Loss (Hearing Impairment) 01/2019
1	Hippocampal Sclerosis 01/2018
1	Cerebral Hemorrhage 01/2018
1	Critical Illness (Critically Ill) 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2017
1	Neoplasms (Cancer) 10/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2015
1	Essential Tremor (Essential Tremors) 05/2015
1	Tremor (Tremors) 05/2015
1	Prehypertension 10/2014
1	Confusion (Bewilderment) 01/2013
1	Parkinson Disease (Parkinson's Disease) 03/2010

Drug/Important Bio-Agent (IBA)

4	C-Reactive ProteinIBA 01/2022 - 01/2017
4	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 10/2014
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2017
4	LDL CholesterolIBA 12/2020 - 01/2018
3	Particulate MatterIBA 01/2021 - 01/2018
3	LipidsIBA 12/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2014
3	ApolipoproteinsIBA 01/2019 - 01/2019
2	CholesterolIBA 01/2020 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2018 - 11/2016
2	SootIBA 01/2017 - 05/2014
1	CopperIBA 06/2022
1	OzoneIBA 01/2021
1	oxidized low density lipoproteinIBA 12/2020
1	Uric Acid (Urate)IBA 07/2020
1	AntioxidantsIBA 07/2020
1	florbetapirIBA 01/2020
1	Troponin T (Troponin T1)IBA 11/2019
1	pro-brain natriuretic peptide (1-76)IBA 11/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2019
1	Apolipoproteins B (ApoB)IBA 01/2019
1	1,5-anhydroglucitolIBA 01/2019
1	AlbuminsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	FructosamineIBA 01/2019
1	Lipoprotein(a)IBA 01/2019
1	Amyloid beta-PeptidesIBA 01/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	beta-hexachlorocyclohexaneIBA 10/2017
1	PesticidesIBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 05/2017
1	Proteins (Proteins, Gene)FDA Link 03/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2016
1	nasIBA 11/2015
1	Oxidoreductases (Dehydrogenase)IBA 05/2015
1	Aminolevulinic Acid (Levulan)FDA Link 05/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2015
1	perfluorohexanesulfonic acidIBA 01/2013
1	perfluoro-n-nonanoic acidIBA 01/2013
1	perfluorooctane sulfonic acidIBA 01/2013
1	perfluorooctanoic acidIBA 01/2013
1	Pharmaceutical PreparationsIBA 03/2010

Therapy/Procedure

2	Activities of Daily Living (ADL) 01/2022 - 12/2021
2	Therapeutics 08/2019 - 03/2017
1	Stethoscopes 01/2022
1	Secondary Prevention 01/2021
1	Complementary Therapies (Alternative Medicine) 08/2019
1	Glycemic Control 01/2019
1	Early Ambulation 01/2018
1	Critical Care (Surgical Intensive Care) 01/2018